Herpesviral infection and Toll-like receptor 2

Protein and Cell

Volumn 3, Issue 8, 2012, Pages 590-601

  Cai, Ming sheng ^a,b   Li, Mei li ^c   Zheng, Chun fu ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b Department of Veterinary Medicine Foshan Science and Technology University ^*  (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

herpesviruses; innate immune; TLR2; Toll like receptor (TLR)

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CHEMOKINE CCL9; CHEMOKINE CXCL4; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES VIRUS; HERPES VIRUS INFECTION; HERPES ZOSTER; HUMAN; IMMUNE EVASION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; MURINE GAMMAHERPESVIRUS 68; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VARICELLA ZOSTER VIRUS; VIRUS CELL INTERACTION;

HERPESVIRIDAE;

EID: 84865744776     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-012-2059-9     Document Type: Review

References (123)

1. Akira, S., and Takeda, K. (2004). Toll-like receptor signalling. Nat Rev Immunol 4, 499-511.
2. Akira, S., Takeda, K., and Kaisho, T. (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2, 675-680.
3. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
4. Aliprantis, A. O., Yang, R. B., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., Klimpel, G. R., Godowski, P., and Zychlinsky, A. (1999). Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739.
5. Aravalli, R. N., Hu, S., Rowen, T. N., Palmquist, J. M., and Lokensgard, J. R. (2005). Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175, 4189-4193.
6. Ariza, M. E., Glaser, R., Kaumaya, P. T., Jones, C., and Williams, M. V. (2009). The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J Immunol 182, 851-859.
7. Armien, A. G., Hu, S., Little, M. R., Robinson, N., Lokensgard, J. R., Low, W. C., and Cheeran, M. C. (2010). Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol 20, 738-750.
8. Arvin, A. M., Koropchak, C. M., Williams, B. R., Grumet, F. C., and Foung, S. K. (1986). Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 154, 422-429.
9. Barbalat, R., Lau, L., Locksley, R. M., and Barton, G. M. (2009). Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 10, 1200-1207.
10. Bieback, K., Lien, E., Klagge, I. M., Avota, E., Schneider-Schaulies, J., Duprex, W. P., Wagner, H., Kirschning, C. J., Ter Meulen, V., and Schneider-Schaulies, S. (2002). Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76, 8729-8736.
11. Bochud, P. Y., Magaret, A. S., Koelle, D. M., Aderem, A., and Wald, A. (2007). Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection. J Infect Dis 196, 505-509.
12. Boehme, K. W., Guerrero, M., and Compton, T. (2006). Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177, 7094-7102.
13. Boivin, G., Coulombe, Z., and Rivest, S. (2002). Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain. Eur J Neurosci 16, 29-43.
14. Bowie, A. G., and Unterholzner, L. (2008). Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8, 911-922.
15. Buwitt-Beckmann, U., Heine, H., Wiesmuller, K. H., Jung, G., Brock, R., Akira, S., and Ulmer, A. J. (2005). Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol 35, 282-289.
16. Chang, J. H., McCluskey, P. J., and Wakefield, D. (2006). Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol 90, 103-108.
17. Chuang, T., and Ulevitch, R. J. (2001). Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 1518, 157-161.
18. Chuang, T. H., and Ulevitch, R. J. (2000). Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 11, 372-378.
19. Compton, T., Kurt-Jones, E. A., Boehme, K. W., Belko, J., Latz, E., Golenbock, D. T., and Finberg, R. W. (2003). Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77, 4588-4596.
20. Cooper, A., Tal, G., Lider, O., and Shaul, Y. (2005). Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol 175, 3165-3176.
21. Crumpacker CS, W. S. (2005). Cytomegalovirus. In Principles and Practice of Infectious Diseases, B. J. Mandell GL, Dolin R, ed. (New York, Churchill Livingstone), pp. 1786-1801.
22. Dolganiuc, A., Oak, S., Kodys, K., Golenbock, D. T., Finberg, R. W., Kurt-Jones, E., and Szabo, G. (2004). Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127, 1513-1524.
23. Du, X., Poltorak, A., Wei, Y., and Beutler, B. (2000). Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 11, 362-371.
24. Duesberg, U., von dem Bussche, A., Kirschning, C., Miyake, K., Sauerbruch, T., and Spengler, U. (2002). Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)-core protein is mediated by toll like receptors (TLRs) 2 and 4. Immunol Lett 84, 89-95.
25. Dziarski, R., Tapping, R. I., and Tobias, P. S. (1998). Binding of bacterial peptidoglycan to CD14. J Biol Chem 273, 8680-8690.
26. Elsawa, S. F., and Bost, K. L. (2004). Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis. J Immunol 172, 516-524.
27. Espevik, T., Otterlei, M., Skjak-Braek, G., Ryan, L., Wright, S. D., and Sundan, A. (1993). The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol 23, 255-261.
28. Feire, A. L., Koss, H., and Compton, T. (2004). Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci U S A 101, 15470-15475.
29. Fitch, M. T., and van de Beek, D. (2008). Drug Insight: steroids in CNS infectious diseases-new indications for an old therapy. Nat Clin Pract Neurol 4, 97-104.
30. Gaudreault, E., Fiola, S., Olivier, M., and Gosselin, J. (2007). Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol 81, 8016-8024.
31. Gay, N. J., and Gangloff, M. (2007). Structure and function of Toll receptors and their ligands. Annu Rev Biochem 76, 141-165.
32. Glaser, R., Litsky, M. L., Padgett, D. A., Baiocchi, R. A., Yang, E. V., Chen, M., Yeh, P. E., Green-Church, K. B., Caligiuri, M. A., and Williams, M. V. (2006). EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease. Virology 346, 205-218.
33. Gordon, S. (2002). Pattern recognition receptors: doubling up for the innate immune response. Cell 111, 927-930.
34. Guo, W., and Giancotti, F. G. (2004). Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5, 816-826.
35. Haller, O., Kochs, G., and Weber, F. (2006). The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344, 119-130.
36. Harwani, S. C., Lurain, N. S., Zariffard, M. R., and Spear, G. T. (2007). Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue. Virol J 4, 133.
37. Haziot, A., Ferrero, E., Kontgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C. L., and Goyert, S. M. (1996). Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4, 407-414.
38. Heise, M. T., and Virgin, H. W. T. (1995). The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol 69, 904-909.
39. Hellman, J., Tehan, M. M., and Warren, H. S. (2003). Murein lipoprotein, peptidoglycan-associated lipoprotein, and outer membrane protein A are present in purified rough and smooth lipopolysaccharides. J Infect Dis 188, 286-289.
40. Herbst-Kralovetz, M., and Pyles, R. (2006). Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 13, 37-41.
41. Hiscott, J., Nguyen, T. L., Arguello, M., Nakhaei, P., and Paz, S. (2006). Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 25, 6844-6867.
42. Horng, T., Barton, G. M., Flavell, R. A., and Medzhitov, R. (2002). The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329-333.
43. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S., and Hartmann, G. (2002). Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168, 4531-4537.
44. Ingalls, R. R., Heine, H., Lien, E., Yoshimura, A., and Golenbock, D. (1999). Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect Dis Clin North Am 13, 341-353, vii.
45. Janeway, C. A., Jr. (1989). Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54Pt 1, 1-13.
46. Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., et al. (2005). CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6, 565-570.
47. Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11, 373-384.
48. Kawai, T., and Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650.
49. Kijpittayarit, S., Eid, A. J., Brown, R. A., Paya, C. V., and Razonable, R. R. (2007). Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 44, 1315-1320.
50. Kinashi, T. (2005). Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 5, 546-559.
51. Kirschning, C. J., Wesche, H., Merrill Ayres, T., and Rothe, M. (1998). Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188, 2091-2097.
52. Koenig, A., and Wolff, M. H. (2003). Infectibility of separated peripheral blood mononuclear cell subpopulations by varicella-zoster virus (VZV). J Med Virol 70Suppl 1, S59-63.
53. Ku, C. L., Yang, K., Bustamante, J., Puel, A., von Bernuth, H., Santos, O. F., Lawrence, T., Chang, H. H., Al-Mousa, H., Picard, C., et al. (2005). Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol Rev 203, 10-20.
54. Kurt-Jones, E. A., Belko, J., Yu, C., Newburger, P. E., Wang, J., Chan, M., Knipe, D. M., and Finberg, R. W. (2005). The role of toll-like receptors in herpes simplex infection in neonates. J Infect Dis 191, 746-748.
55. Kurt-Jones, E. A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., Arnold, M. M., Knipe, D. M., and Finberg, R. W. (2004). Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 101, 1315-1320.
56. L, C. (2005). Herpes Simplex Virus. In Principles and Practice of Infectious Diseases, B. J. Mandell GL, Dolin R, ed. (New York, Churchill Livingstone), pp. 1762-1780.
57. Lee, H. K., Lee, J., and Tobias, P. S. (2002). Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J Immunol 168, 4012-4017.
58. Lee, R. M., White, M. R., and Hartshorn, K. L. (2006). Influenza a viruses upregulate neutrophil toll-like receptor 2 expression and function. Scand J Immunol 63, 81-89.
59. Lorenz, E., Mira, J. P., Cornish, K. L., Arbour, N. C., and Schwartz, D. A. (2000). A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68, 6398-6401.
60. Lundberg, P., Ramakrishna, C., Brown, J., Tyszka, J. M., Hamamura, M., Hinton, D. R., Kovats, S., Nalcioglu, O., Weinberg, K., Openshaw, H., et al. (2008). The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol 82, 7078-7088.
61. Marques, C. P., Cheeran, M. C., Palmquist, J. M., Hu, S., and Lokensgard, J. R. (2008a). Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J Neurovirol 14, 229-238.
62. Marques, C. P., Cheeran, M. C., Palmquist, J. M., Hu, S., Urban, S. L., and Lokensgard, J. R. (2008b). Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol 181, 6417-6426.
63. Marques, C. P., Hu, S., Sheng, W., and Lokensgard, J. R. (2006). Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res 121, 1-10.
64. McGeoch, D. J., Dolan, A., and Ralph, A. C. (2000). Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J Virol 74, 10401-10406.
65. McGettrick, A. F., and O'Neill, L. A. (2004). The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol Immunol 41, 577-582.
66. Means, T. K., Lien, E., Yoshimura, A., Wang, S., Golenbock, D. T., and Fenton, M. J. (1999). The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 163, 6748-6755.
67. Medzhitov, R. (2001). Toll-like receptors and innate immunity. Nat Rev Immunol 1, 135-145.
68. Medzhitov, R., Preston-Hurlburt, P., and Janeway, C. A., Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397.
69. Melchjorsen, J., Pedersen, F. S., Mogensen, S. C., and Paludan, S. R. (2002). Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0. J Virol 76, 2780-2788.
70. Michaud, F., Coulombe, F., Gaudreault, E., Kriz, J., and Gosselin, J. (2010). Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection. PLoS One 5, e13742.
71. Mogensen, T. H., and Paludan, S. R. (2005). Reading the viral signature by Toll-like receptors and other pattern recognition receptors. J Mol Med (Berl) 83, 180-192.
72. Morrison, L. A. (2004). The Toll of herpes simplex virus infection. Trends Microbiol 12, 353-356.
73. Ogawa, T., Asai, Y., Hashimoto, M., and Uchida, H. (2002). Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2, CD14 and CD11a/CD18 as cellular receptors. Eur J Immunol 32, 2543-2550.
74. Ogus, A. C., Yoldas, B., Ozdemir, T., Uguz, A., Olcen, S., Keser, I., Coskun, M., Cilli, A., and Yegin, O. (2004). The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23, 219-223.
75. Olson, J. K., and Miller, S. D. (2004). Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173, 3916-3924.
76. Paludan, S. R. (2001). Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol 75, 8008-8015.
77. Pellett PE, R. B. (2007). The family Herpesviridae: a brief introduction. In Fields virology, H. P. Knipe DM ed. (Philadelphia, Lippincott Williams and Wilkins), pp. 2479-2500.
78. Randall, R. E., and Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89, 1-47.
79. Reske, A., Pollara, G., Krummenacher, C., Katz, D. R., and Chain, B. M. (2008). Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J Immunol 180, 7525-7536.
80. Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A., and Bazan, J. F. (1998). A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 95, 588-593.
81. Roizman B, K. D., Whitley RJ. (2007). Herpes simplex viruses. In Fields Virology, H. P. Knipe DM, ed. (Philadelphia, Lippincott Williams and Wilkins), pp. 2501-2602.
82. Roy, C. R., and Mocarski, E. S. (2007). Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol 8, 1179-1187.
83. Sabroe, I., Read, R. C., Whyte, M. K., Dockrell, D. H., Vogel, S. N., and Dower, S. K. (2003). Toll-like receptors in health and disease: complex questions remain. J Immunol 171, 1630-1635.
84. Sarangi, P. P., Kim, B., Kurt-Jones, E., and Rouse, B. T. (2007). Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 81, 11128-11138.
85. Sarawar, S. R., Cardin, R. D., Brooks, J. W., Mehrpooya, M., Tripp, R. A., and Doherty, P. C. (1996). Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol 70, 3264-3268.
86. Sarawar, S. R., Lee, B. J., and Giannoni, F. (2004). Cytokines and costimulatory molecules in the immune response to murine gammaherpesvirus-68. Viral Immunol 17, 3-11.
87. Sato, A., Linehan, M. M., and Iwasaki, A. (2006). Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A 103, 17343-17348.
88. Schroder, N. W., Morath, S., Alexander, C., Hamann, L., Hartung, T., Zahringer, U., Gobel, U. B., Weber, J. R., and Schumann, R. R. (2003). Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278, 15587-15594.
89. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. J. (1999). Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274, 17406-17409.
90. Schwartz, D. A., and Cook, D. N. (2005). Polymorphisms of the Toll-like receptors and human disease. Clin Infect Dis 41Suppl 7, S403-407.
91. Sergerie, Y., Boivin, G., Gosselin, D., and Rivest, S. (2007). Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. J Infect Dis 195, 817-825.
92. Simmen, K. A., Singh, J., Luukkonen, B. G., Lopper, M., Bittner, A., Miller, N. E., Jackson, M. R., Compton, T., and Fruh, K. (2001). Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A 98, 7140-7145.
93. Soderberg-Naucler, C., and Nelson, J. Y. (1999). Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system. Intervirology 42, 314-321.
94. Sorensen, L. N., Reinert, L. S., Malmgaard, L., Bartholdy, C., Thomsen, A. R., and Paludan, S. R. (2008). TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol 181, 8604-8612.
95. Szomolanyi-Tsuda, E., Liang, X., Welsh, R. M., Kurt-Jones, E. A., and Finberg, R. W. (2006). Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol 80, 4286-4291.
96. Takeda, K., and Akira, S. (2003). Toll receptors and pathogen resistance. Cell Microbiol 5, 143-153.
97. Takeda, K., Kaisho, T., and Akira, S. (2003). Toll-like receptors. Annu Rev Immunol 21, 335-376.
98. Takeuchi, O., Kawai, T., Sanjo, H., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Takeda, K., and Akira, S. (1999). TLR6: A novel member of an expanding toll-like receptor family. Gene 231, 59-65.
99. Texereau, J., Chiche, J. D., Taylor, W., Choukroun, G., Comba, B., and Mira, J. P. (2005). The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 41Suppl 7, S408-415.
100. Thorley-Lawson, D. A., Duca, K. A., and Shapiro, M. (2008). Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality. Trends Immunol 29, 195-201.
101. Torigo, S., Ihara, T., and Kamiya, H. (2000). IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiol Immunol 44, 1027-1031.
102. Town, T., Jeng, D., Alexopoulou, L., Tan, J., and Flavell, R. A. (2006). Microglia recognize double-stranded RNA via TLR3. J Immunol 176, 3804-3812.
103. Triantafilou, M., and Triantafilou, K. (2002). Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 23, 301-304.
104. Tsuchida, T., Kawai, T., and Akira, S. (2009). Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins. Cell Res 19, 3-4.
105. Underhill, D. M., Ozinsky, A., Hajjar, A. M., Stevens, A., Wilson, C. B., Bassetti, M., and Aderem, A. (1999). The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811-815.
106. Unterholzner, L., and Bowie, A. G. (2008). The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochem Pharmacol 75, 589-602.
107. van Lint, A. L., Murawski, M. R., Goodbody, R. E., Severa, M., Fitzgerald, K. A., Finberg, R. W., Knipe, D. M., and Kurt-Jones, E. A. (2010). Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J Virol 84, 10802-10811.
108. Vollstedt, S., Franchini, M., Alber, G., Ackermann, M., and Suter, M. (2001). Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1. J Virol 75, 9596-9600.
109. von Aulock, S., Schroder, N. W., Traub, S., Gueinzius, K., Lorenz, E., Hartung, T., Schumann, R. R., and Hermann, C. (2004). Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses. Infect Immun 72, 1828-1831.
110. Waldman, W. J., Williams, M. V., Jr., Lemeshow, S., Binkley, P., Guttridge, D., Kiecolt-Glaser, J. K., Knight, D. A., Ladner, K. J., and Glaser, R. (2008). Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk. Brain Behav Immun 22, 215-223.
111. Wang, J. P., Kurt-Jones, E. A., Shin, O. S., Manchak, M. D., Levin, M. J., and Finberg, R. W. (2005a). Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol 79, 12658-12666.
112. Wang, X., Huang, D. Y., Huong, S. M., and Huang, E. S. (2005b). Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Nat Med 11, 515-521.
113. Weber, F., and Haller, O. (2007). Viral suppression of the interferon system. Biochimie 89, 836-842.
114. Weber, O. (2000). Novel mouse models for the investigation of experimental drugs with activity against human varicella-zoster virus. Antivir Chem Chemother 11, 283-290.
115. Weidemann, B., Schletter, J., Dziarski, R., Kusumoto, S., Stelter, F., Rietschel, E. T., Flad, H. D., and Ulmer, A. J. (1997). Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun 65, 858-864.
116. Whitley RJ, H. J. (2001). Cercopithecine herpesvirus (B virus). In Fields Virology, H. P. Knipe DM, ed. (Philadelphia, Lippincott Williams and Wilkins), pp. 2835-2848.
117. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.
118. Yang, R. B., Mark, M. R., Gray, A., Huang, A., Xie, M. H., Zhang, M., Goddard, A., Wood, W. I., Gurney, A. L., and Godowski, P. J. (1998). Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395, 284-288.
119. Zarember, K. A., and Godowski, P. J. (2002). Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168, 554-561.
120. Zhang, D., Zhang, G., Hayden, M. S., Greenblatt, M. B., Bussey, C., Flavell, R. A., and Ghosh, S. (2004). A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303, 1522-1526.
121. Zhang, G., and Ghosh, S. (2001). Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107, 13-19.
122. Zhou, S., Kurt-Jones, E. A., Mandell, L., Cerny, A., Chan, M., Golenbock, D. T., and Finberg, R. W. (2005). MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur J Immunol 35, 822-830.
123. Zhu, J., Martinez, J., Huang, X., and Yang, Y. (2007). Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood 109, 619-625.